Literature DB >> 21906707

Usefulness of thrombus aspiration for the treatment of coronary stent thrombosis.

Karim D Mahmoud1, Pieter J Vlaar, Ad F M van den Heuvel, Hans L Hillege, Felix Zijlstra, Bart J G L de Smet.   

Abstract

Current treatment for coronary stent thrombosis (ST) often lacks satisfactory results and clinical outcome is poor. We investigated the impact of manual thrombus aspiration during percutaneous coronary intervention (PCI) on myocardial reperfusion and clinical outcome in patients with angiographically proved ST. We interrogated our PCI registry for patients with a first stent placement from January 2002 through May 2010 who had undergone an emergency repeated PCI procedure and systematically reviewed coronary angiograms and hospital records for evidence of ST. We identified 113 patients with ST. Thrombus aspiration was used in 51 patients and 62 patients received conventional PCI. Histopathologic analysis of thrombus aspirates was performed in 6 patients. Use of thrombus aspiration predicted postprocedure Thrombolysis In Myocardial Infarction grade 3 flow (odds ratio 3.16, 95% confidence interval 1.22 to 8.17, p = 0.018) and myocardial blush grade 2/3 (odds ratio 3.20, 95% confidence interval 1.20 to 8.55, p = 0.020) after multivariable adjustment with bootstrap model selection. Distal embolization was lower in the thrombus aspiration group compared to the conventional PCI group (14% vs 37%, p = 0.017). In most patients, aspirated thrombus was large and contained platelet and erythrocyte components at histopathologic analysis. Mortality in the thrombus aspiration group and conventional PCI group was 9.8% versus 16% at 30 days (p = 0.351) and 12% versus 21% at 1 year (p = 0.220), respectively. In conclusion, use of manual thrombus aspiration in patients with ST was associated with greater epicardial and microvascular myocardial reperfusion. In addition, mortality was lower in patients treated with thrombus aspiration, although not statistically significant.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21906707     DOI: 10.1016/j.amjcard.2011.07.044

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Efficacy of Endeavor zotarolimus-eluting stent implantation for the treatment of very late stent thrombosis with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation.

Authors:  Yuki Kakefuda; Akira Sato; Hiroaki Watabe; Hideaki Aihara; Hidetaka Nishina; Yuichi Noguchi; Tomoya Hoshi; Kazutaka Aonuma
Journal:  Heart Vessels       Date:  2015-07-29       Impact factor: 2.037

Review 2.  Thrombus aspiration in acute myocardial infarction.

Authors:  Karim D Mahmoud; Felix Zijlstra
Journal:  Nat Rev Cardiol       Date:  2016-03-10       Impact factor: 32.419

3.  Short-term consequences of angiographically-confirmed coronary stent thrombosis.

Authors:  Christine G Kohn; Jeffrey Kluger; Meena Azeem; Craig I Coleman
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

4.  Early stent thrombosis. Aetiology, treatment, and prognosis.

Authors:  Paweł Tyczyński; Maciej A Karcz; Lukasz Kalińczuk; Aneta Fronczak; Adam Witkowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-11-17       Impact factor: 1.426

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.